To Top

INVESTORS

Company Information

Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company committed to the development of first-in-class, effective therapies by harnessing the power of the tumor microenvironment (TME) to overcome drug resistance and improve treatment outcomes for cancer patients

 

Stock Info

Corporate Presentation

Stock Chart

Upcoming Events

Views Navigation

Event Views Navigation

Today

Press Releases

SEC Filings

Shareholders Meetings

DateFiles
August 25, 2022ea163003-6k_purplebioEDGAR2_Bannerless Instructions-and-Voting-Card-for-2022-GM PURPLE-BIOTECH-LTD-VIF
Dec 22, 2021Purple-Biotech-Ltd_6-K_Voting-Slip Purple-Biotech-Ltd_6-K_Notice-and-Proxy-Statement 17865-PURPLE-BIOTECH-LTD-KITOV-VIF

Email alerts

Corporate Governance

Purple Biotech Ltd.’s Board of Directors sets high standards for the Company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company’s business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Corporate Governance Documents
Code of EthicsDownload
Audit Committee CharterDownload
Compensation Committee CharterDownload
Board Diversity MatrixDownload
Audit CommitteeCompensation Committee
Independent Directors
Dr. Eric Rowinsky
Simcha Rockicon-member
Ido Agmonicon-member-chair-person
Steven Steinbergicon-member-chair-personicon-member
Robert Gagnonicon-member
Suzana Nahum-Zilberbergicon-member
Ori Hershkovitz
Non-independent Directors
Isaac Israel
icon-memberMember icon-chair-personChair
Skip to content